• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-肾上腺素能药物在运动员哮喘管理中的应用

Beta-adrenergic drugs in the management of asthma in athletes.

作者信息

Sly R M

出版信息

J Allergy Clin Immunol. 1984 May;73(5 Pt 2):680-5. doi: 10.1016/0091-6749(84)90305-1.

DOI:10.1016/0091-6749(84)90305-1
PMID:6143770
Abstract

beta-Adrenergic drugs are effective as bronchodilators and as inhibitors of exercise-induced asthma. Inhalation is the route of choice, but technique determines adequacy of delivery of the drug to the lower airways. The duration of bronchodilation can differ from the duration of inhibition of exercise-induced asthma. Albuterol aerosol usually prevents exercise-induced asthma for 4 to 6 hr, but metaproterenol aerosol affords protection to most asthmatics for less than 2 hr. Albuterol aerosol is the drug of choice for prevention of exercise-induced asthma. When a beta-adrenergic drug alone does not afford adequate protection, addition of theophylline, cromolyn, or an inhaled corticosteroid may enhance protection.

摘要

β-肾上腺素能药物作为支气管扩张剂和运动诱发性哮喘的抑制剂是有效的。吸入是首选途径,但技术决定了药物向下呼吸道输送的充分性。支气管扩张的持续时间可能与运动诱发性哮喘抑制的持续时间不同。沙丁胺醇气雾剂通常可预防运动诱发性哮喘4至6小时,但间羟异丙肾上腺素气雾剂对大多数哮喘患者的保护作用不到2小时。沙丁胺醇气雾剂是预防运动诱发性哮喘的首选药物。当单独使用β-肾上腺素能药物不能提供足够的保护时,添加茶碱、色甘酸或吸入性皮质类固醇可能会增强保护作用。

相似文献

1
Beta-adrenergic drugs in the management of asthma in athletes.β-肾上腺素能药物在运动员哮喘管理中的应用
J Allergy Clin Immunol. 1984 May;73(5 Pt 2):680-5. doi: 10.1016/0091-6749(84)90305-1.
2
The use of anti-asthmatic drugs. Do they affect sports performance?抗哮喘药物的使用。它们会影响运动表现吗?
Sports Med. 1986 Mar-Apr;3(2):136-50. doi: 10.2165/00007256-198603020-00004.
3
Evaluation of reproterol's effectiveness in preventing exercise-induced bronchospasm in children.瑞普特罗预防儿童运动诱发性支气管痉挛有效性的评估。
J Int Med Res. 1985;13(1):19-23. doi: 10.1177/030006058501300103.
4
Duration of protection by inhaled salmeterol in exercise-induced asthma.吸入沙美特罗对运动诱发性哮喘的保护时长。
Chest. 1991 Nov;100(5):1254-60. doi: 10.1378/chest.100.5.1254.
5
The duration of protection from exercise-induced asthma by inhaled salbutamol, and a comparison with inhaled reproterol.吸入沙丁胺醇对运动诱发性哮喘的保护时长以及与吸入瑞普特罗的比较。
Br J Dis Chest. 1983 Jul;77(3):262-9.
6
Controversies in asthma therapy with theophylline and the beta 2-adrenergic agonists.茶碱与β2肾上腺素能激动剂在哮喘治疗中的争议。
Clin Pharm. 1984 Jul-Aug;3(4):386-95.
7
Duration of protective effect of terbutaline sulfate and cromolyn sodium alone and in combination on exercise-induced asthma.硫酸特布他林和色甘酸钠单独及联合使用对运动诱发性哮喘的保护作用持续时间。
Chest. 1990 Jan;97(1):39-45. doi: 10.1378/chest.97.1.39.
8
Cromoglycate, reproterol, or both--what's best for exercise-induced asthma?色甘酸钠、丙卡特罗还是两者都用——治疗运动性哮喘哪种最好?
Sleep Breath. 2012 Dec;16(4):1229-35. doi: 10.1007/s11325-011-0638-2. Epub 2011 Dec 27.
9
Bronchodilators: new drugs and controversies.支气管扩张剂:新药与争议
Curr Opin Pulm Med. 1997 Jan;3(1):17-22.
10
Terbutaline: a preliminary report of its pharmacological properties and therapeutic efficacy in asthma.特布他林:其药理特性及在哮喘治疗中疗效的初步报告
Drugs. 1973;6(5):324-32. doi: 10.2165/00003495-197306050-00002.

引用本文的文献

1
Pediatric athletic asthmatics.小儿运动性哮喘患者
Curr Allergy Asthma Rep. 2008 Nov;8(6):500-4. doi: 10.1007/s11882-008-0091-x.
2
Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction.肥大细胞稳定剂预防运动诱发的支气管收缩。
Cochrane Database Syst Rev. 2003;2003(4):CD002307. doi: 10.1002/14651858.CD002307.
3
Nedocromil sodium vs. sodium cromoglycate for preventing exercise-induced bronchoconstriction in asthmatics.奈多罗米钠与色甘酸钠预防哮喘患者运动诱发性支气管收缩的比较
Cochrane Database Syst Rev. 2000;2000(4):CD002731. doi: 10.1002/14651858.CD002731.
4
Nedocromil sodium for preventing exercise-induced bronchoconstriction.用于预防运动诱发性支气管收缩的奈多罗米钠
Cochrane Database Syst Rev. 2000;2002(2):CD001183. doi: 10.1002/14651858.CD001183.
5
Exercise and the asthmatic patient.运动与哮喘患者
Bull N Y Acad Med. 1986 May;62(4):315-23.
6
Exercise-induced asthma in athletes.运动员运动诱发的哮喘
Sports Med. 1988 Oct;6(4):193-6. doi: 10.2165/00007256-198806040-00001.
7
Exercise and training in patients with chronic obstructive lung disease.慢性阻塞性肺疾病患者的运动与训练
Sports Med. 1988 Sep;6(3):180-92. doi: 10.2165/00007256-198806030-00005.
8
The use of anti-asthmatic drugs. Do they affect sports performance?抗哮喘药物的使用。它们会影响运动表现吗?
Sports Med. 1986 Mar-Apr;3(2):136-50. doi: 10.2165/00007256-198603020-00004.
9
Effect of nebulised salbutamol on maximal exercise performance in men with mild asthma.雾化吸入沙丁胺醇对轻度哮喘男性最大运动能力的影响。
Thorax. 1989 Nov;44(11):942-7. doi: 10.1136/thx.44.11.942.
10
Benefits and problems of a physical training programme for asthmatic patients.哮喘患者体育锻炼计划的益处与问题
Thorax. 1990 May;45(5):345-51. doi: 10.1136/thx.45.5.345.